17-46931204-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004287.5(GOSR2):​c.200G>A​(p.Arg67Lys) variant causes a missense change. The variant allele was found at a frequency of 0.343 in 1,435,212 control chromosomes in the GnomAD database, including 85,927 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R67Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.33 ( 8426 hom., cov: 32)
Exomes 𝑓: 0.34 ( 77501 hom. )

Consequence

GOSR2
NM_004287.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 3.76
Variant links:
Genes affected
GOSR2 (HGNC:4431): (golgi SNAP receptor complex member 2) This gene encodes a trafficking membrane protein which transports proteins among the medial- and trans-Golgi compartments. Due to its chromosomal location and trafficking function, this gene may be involved in familial essential hypertension. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017098784).
BP6
Variant 17-46931204-G-A is Benign according to our data. Variant chr17-46931204-G-A is described in ClinVar as [Benign]. Clinvar id is 129165.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-46931204-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.434 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GOSR2NM_004287.5 linkuse as main transcriptc.200G>A p.Arg67Lys missense_variant 3/6 ENST00000640051.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GOSR2ENST00000640051.2 linkuse as main transcriptc.200G>A p.Arg67Lys missense_variant 3/61 NM_004287.5 P3O14653-1

Frequencies

GnomAD3 genomes
AF:
0.331
AC:
50302
AN:
151950
Hom.:
8433
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.296
Gnomad AMI
AF:
0.420
Gnomad AMR
AF:
0.308
Gnomad ASJ
AF:
0.241
Gnomad EAS
AF:
0.385
Gnomad SAS
AF:
0.452
Gnomad FIN
AF:
0.385
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.328
GnomAD3 exomes
AF:
0.346
AC:
86785
AN:
250870
Hom.:
15261
AF XY:
0.351
AC XY:
47649
AN XY:
135606
show subpopulations
Gnomad AFR exome
AF:
0.300
Gnomad AMR exome
AF:
0.296
Gnomad ASJ exome
AF:
0.240
Gnomad EAS exome
AF:
0.367
Gnomad SAS exome
AF:
0.427
Gnomad FIN exome
AF:
0.380
Gnomad NFE exome
AF:
0.346
Gnomad OTH exome
AF:
0.329
GnomAD4 exome
AF:
0.345
AC:
442665
AN:
1283142
Hom.:
77501
Cov.:
20
AF XY:
0.348
AC XY:
225495
AN XY:
647642
show subpopulations
Gnomad4 AFR exome
AF:
0.294
Gnomad4 AMR exome
AF:
0.298
Gnomad4 ASJ exome
AF:
0.242
Gnomad4 EAS exome
AF:
0.411
Gnomad4 SAS exome
AF:
0.428
Gnomad4 FIN exome
AF:
0.378
Gnomad4 NFE exome
AF:
0.341
Gnomad4 OTH exome
AF:
0.329
GnomAD4 genome
AF:
0.331
AC:
50313
AN:
152070
Hom.:
8426
Cov.:
32
AF XY:
0.335
AC XY:
24863
AN XY:
74326
show subpopulations
Gnomad4 AFR
AF:
0.296
Gnomad4 AMR
AF:
0.307
Gnomad4 ASJ
AF:
0.241
Gnomad4 EAS
AF:
0.385
Gnomad4 SAS
AF:
0.450
Gnomad4 FIN
AF:
0.385
Gnomad4 NFE
AF:
0.340
Gnomad4 OTH
AF:
0.329
Alfa
AF:
0.333
Hom.:
21819
Bravo
AF:
0.320
TwinsUK
AF:
0.344
AC:
1275
ALSPAC
AF:
0.345
AC:
1329
ESP6500AA
AF:
0.307
AC:
1354
ESP6500EA
AF:
0.334
AC:
2870
ExAC
AF:
0.349
AC:
42364
Asia WGS
AF:
0.387
AC:
1349
AN:
3478
EpiCase
AF:
0.338
EpiControl
AF:
0.345

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 09, 2014- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 51% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 47. Only high quality variants are reported. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 20, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015This variant is associated with the following publications: (PMID: 19057520) -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Progressive myoclonic epilepsy Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Myoclonic epilepsy, progressive, X-linked Benign:1
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 08, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Progressive myoclonic epilepsy type 6 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
14
DANN
Benign
0.74
DEOGEN2
Benign
0.027
.;.;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.50
T;T;T;T;T;T;T;T;T;T;.;T;T;.;T;T;T;T;T;T;.;T;T
MetaRNN
Benign
0.0017
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-1.7
.;.;.;N;.;.;N;.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
P;P;P;P;P;P
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
2.4
.;.;.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.078
Sift
Benign
1.0
.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
1.0
.;.;.;T;.;.;.;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.
Polyphen
0.0
.;.;.;B;.;.;B;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.050, 0.11
MPC
0.17
ClinPred
0.0082
T
GERP RS
4.8
Varity_R
0.12
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs197922; hg19: chr17-45008570; COSMIC: COSV56661149; COSMIC: COSV56661149; API